I spoke with customer service. The agent steered me to the report which was published via. Consumer Reports News. The person steered me to the report (reached via searching Belviq on the Consumer Reports website News page) and I pointed out that there 11 comments posted there all of which said the report was seriously misleading. His bottom line is - we are entitled to report what we think and he gave no indication that a retraction or correction would issue. Totally disgusting and for an organization that is supposed to function in the Public Interest a badge of failure. I am a retired attorney but cannot think of a legal remedy here, although Arena may have one.
Hedge funds and dark pools are driving the price down in order to get it cheaper because they know it will soar once sales start. Do we still have an SEC? In the good old days good news about a stock would drive the price up. Hold, IMO you'll be richly rewarded.
I had a phone call today from a DEA investigator in response to either my April 2013 email to my Congress person or my May 2013 email to the DOJ Inspector General in which I told them that I thought there could be some skullduggery in the DEA’s delay in classifying Lorcasin.
I was assured that the delay would be investigated but I hope the call was not simply to enable DEA to get back to my Congress person saying they had contacted me and resolved the situation
From Insider Monkey - At the end of the first quarter, a total of 19 of the hedge funds we track were bullish in this stock, a change of 19% from the first quarter. With hedge funds' capital changing hands, there exists a few key hedge fund managers who were increasing their holdings substantially.
According to our comprehensive database , Perceptive Advisors, managed by Joseph Edelman, holds the largest position in Sarepta Therapeutics Inc (NASDAQ:SRPT). Perceptive Advisors has a $99.3 million position in the stock, comprising 11.9% of its 13F portfolio. On Perceptive Advisors's heels is Andreas Halvorsen of Viking Global, with a $25.5 million position; the fund has 0.2% of its 13F portfolio invested in the stock. Some other hedgies that are bullish include Steven Cohen's SAC Capital Advisors, George Soros's Soros Fund Management and Joseph Edelman's Perceptive Advisors.
With a general bullishness amongst the heavyweights, key money managers were breaking ground themselves. Viking Global, managed by Andreas Halvorsen, established the largest position in Sarepta Therapeutics Inc (NASDAQ:SRPT). Viking Global had 25.5 million invested in the company at the end of the quarter. James Pallotta's Raptor Capital Management also made a $8.7 million investment in the stock during the quarter. The following funds were also among the new SRPT investors: D. E. Shaw's D E Shaw, Sanford J. Colen's Apex Capital, and SAC Subsidiary's Sigma Capital Management.
vringisdead Do you have any source for their implementing it sometime in May. As you can see the board is mixed on this one. I was hoping for some definitive source of info.
Has anyone seen anything definitive on the current status? Last think I saw was GOOG saying they will have it. If there is nothing definitive saying they got it now, is there anything definitive on when they will have it.
Since the suit against MSFT was about their use of the patents GOOG is being sued about, settlement means to me that MSFT now can use the patents. IMO there is some undisclosed royalty or MSFT's revenue from the patents is so small that the disclosed terms cover it. I think the settlement pressures GOOG by potentially giving MSFT's Bing a search engine monopoly.
We'll find out. IMO the work around is simply a stalling device. We've seen many messages on the topic but I haven't seen anything I consider convincing as to GOOG's having it.
Coolrob - name calling is childish. I'll cuss you out in language you'll understand Cockey Doodle Foo
Will get royalties from MSFT's use of the search engine patents that GOOG can no longer use and GOOG will be under big pressure to settle because MSFT's seargh engine (Bing) will dominate the search engine field.